Evidence map›Paper›PMID 38076966›Full record

ArticlebioRxiv : the preprint server for biology2023

Single-genome analysis reveals heterogeneous association of the Herpes Simplex Virus genome with H3K27me2 and the reader PHF20L1 following infection of human fibroblasts.

Alison K Francois, Ali Rohani, Matt Loftus, Sara Dochnal, Joel Hrit, Steven McFarlane, Abigail Whitford, Anna Lewis, Patryk Krakowiak, Chris Boutell and 3 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Alison K FrancoisDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, 22908.
Ali RohaniDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, 22908.
Matt LoftusDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, 22908.
Sara DochnalDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, 22908.
Joel HritDepartment of Epigenetics, Van Andel Institute, Grand Rapids, MI, 49503.
Steven McFarlaneMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland.
Abigail WhitfordDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, 22908.
Anna LewisDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, 22908.
Patryk KrakowiakDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, 22908.
Chris BoutellMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland.ORCID 0000-0002-2970-7785
Scott B RothbartDepartment of Epigenetics, Van Andel Institute, Grand Rapids, MI, 49503.
David KashatusDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, 22908.
Anna R CliffeDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, 22908.ORCID 0000-0003-1136-5171
University of Virginia · USMRC University of Glasgow Centre for Virus Research · GBVan Andel Institute · US

Funding

INFECTIOUS DISEASES TRAINING PROGRAMT32AI007046 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Alison K Criss, William A Petri · 1985 to 2026
$15.3M
TRAINING IN CELL AND MOLECULAR BIOLOGYT32GM008136 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI STUKENBERG, P. TODD · 1985 to 2020
$8.5M
Defining the regulation of UHRF1 and DNMT1 for maintenance of the epigenomeF32CA260116 · NCI · VAN ANDEL RESEARCH INSTITUTE · PI HRIT, JOEL · 2021 to 2023
$208k
Medical Research Council MC_UU_00034/2Medical Research Council MC_UU_12014/5NCI NIH HHS F32 CA260116NIAID NIH HHS T32 AI007046NIGMS NIH HHS T32 GM008136
6 · The paper itself

Abstract

The fate of herpesvirus genomes following entry into different cell types is thought to regulate the outcome of infection. For the Herpes simplex virus 1 (HSV-1), latent infection of neurons is characterized by association with repressive heterochromatin marked with Polycomb silencing-associated lysine 27 methylation on histone H3 (H3K27me). However, whether H3K27 methylation plays a role in repressing lytic gene expression in non-neuronal cells is unclear. To address this gap in knowledge, and with consideration that the fate of the viral genome and outcome of HSV-1 infection could be heterogeneous, we developed an assay to quantify the abundance of histone modifications within single viral genome foci of infected fibroblasts. Using this approach, combined with bulk epigenetic techniques, we were unable to detect any role for H3K27me3 during HSV-1 lytic infection of fibroblasts. In contrast, we could detect the lesser studied H3K27me2 on a subpopulation of viral genomes, which was consistent with a role for H3K27 demethylases in promoting lytic gene expression. This was consistent with a role for H3K27 demethylases in promoting lytic gene expression. In addition, viral genomes co-localized with the H3K27me2 reader protein PHF20L1, and this association was enhanced by inhibition of the H3K27 demethylases UTX and JMJD3. Notably, targeting of H3K27me2 to viral genomes was enhanced following infection with a transcriptionally defective virus in the absence of Promyelocytic leukemia nuclear bodies. Collectively, these studies implicate a role for H3K27me2 in fibroblast-associated HSV genome silencing in a manner dependent on genome sub-nuclear localization and transcriptional activity.

Identifiers

PMID38076966
PMCPMC10705572
OpenAlexW4389289615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.